Ayala Pharmaceuticals, Inc. (AYLA)

NASDAQ: AYLA · IEX Real-Time Price · USD
1.35
-0.01 (-0.74%)
At close: Aug 12, 2022 4:00 PM
1.38
+0.03 (2.22%)
After-hours: Aug 12, 2022 7:52 PM EDT

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018
Cash & Equivalents
36.9842.0316.7326.1
Short-Term Investments
0.120.090.080.17
Cash & Cash Equivalents
37.142.1216.8126.26
Cash Growth
-11.90%150.57%-36.00%-
Receivables
00.680.470
Other Current Assets
2.641.440.420.59
Total Current Assets
39.7444.2417.6926.85
Property, Plant & Equipment
1.121.281.420.24
Other Long-Term Assets
0.270.310.940.03
Total Long-Term Assets
1.391.592.360.27
Total Assets
41.1345.8320.0527.13
Accounts Payable
6.476.885.32.77
Total Current Liabilities
6.476.885.32.77
Other Long-Term Liabilities
0.50.5553.6746.21
Total Long-Term Liabilities
0.50.5553.6746.21
Total Liabilities
6.977.4358.9748.98
Common Stock
145.3109.291.821.09
Retained Earnings
-111.14-70.89-40.74-22.95
Shareholders' Equity
34.1638.4-38.92-21.86
Total Liabilities and Equity
41.1345.8320.0527.13
Net Cash / Debt
37.142.1216.8126.26
Net Cash / Debt Growth
-11.90%150.57%-36.00%-
Net Cash Per Share
2.584.273.385.32
Working Capital
33.2737.3612.3924.08
Book Value Per Share
2.373.89-7.82-4.43
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).